ALFA Finder| Revenue growth | 23% YoY for FY26; Q4 grew 26% YoY to ₹191cr. |
|---|---|
| Margins | FY26 adjusted EBITDA margin at 14.7%; Q4 adjusted margin at 19%. |
| Order book | New ACV of ₹121cr; organic NRR target remains ~115%. |
| Demand visibility | Strong; added 3-4 Fortune 500 logos and closed $20M deal. |
| Management confidence | High; cited visibility for FY27 revenue exceeding ₹1,000cr. |
Growth
FY26 revenue grew 23% YoY; adjusted EBITDA rose 43% to ₹107cr with 110% Net Retention Rate.
Outlook
FY27 revenue guidance of ₹1,000–1,050cr following SessionM acquisition; targeting 25-30% steady-state EBITDA margins.
Risks
M&A integrations take 12-18 months to margin-accrete; potential Q1 margin softness due to salary increments.
Earnings Call filed with BSE, NSE: CAPILLARY. Summary written with AI assistance from the document.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹510.00
- Market cap
- ₹4,064 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 63.8×Sector 23.6×
- Promoter holding
- 47.23%-4.22% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Earnings Call Transcript: Key Takeaways
Q2 revenue ₹271 Cr (+51% YoY, +43% constant currency), adjusted EBITDA ₹44.8 Cr at 17% margin. Organic H1 growth is 23%; inorganic (Session M) doubled and drove the headline.
- Call
- Guides 20% growth
Capillary Technologies India Employee Stock Options
Capillary Technologies allotted 94,553 equity shares of ₹2 each upon exercise of vested ESOP 2021 options. The allotment was approved by circular resolution on November 04, 2026.
Capillary Technologies India Business Update
Capillary Technologies announced the strategic shutdown of its China operations due to low growth. Both quantitative and qualitative effects of the restructuring are stated as nil.
Capillary Technologies India Management Change
Capillary Technologies replaced internal auditor Protiviti with Deloitte Touche Tohmatsu India LLP on a 15-month term. The board cited expanding international operations as the reason.
Capillary Technologies India Other Announcement
Capillary Technologies appointed Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India. The change takes effect November 02, 2026.
Capillary Technologies India Results Update
Capillary announced Q2 FY27 revenue of ₹2,713.5 Mn (+51% YoY) and Adjusted EBITDA of ₹448.6 Mn (+103%). H1 FY27 revenue grew 47% with EBITDA up 116%.